# A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension

> **NCT02906579** · PHASE2 · COMPLETED · sponsor: **Cyclerion Therapeutics** · enrollment: 11 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Hypertension

## Interventions

- **DRUG:** Matching Placebo
- **DRUG:** IW-1973

## Key facts

- **NCT ID:** NCT02906579
- **Lead sponsor:** Cyclerion Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-03-17
- **Final completion:** 2017-03-17
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02906579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02906579, "A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02906579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*